Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: eRAPID: Online Symptom Reporting in Lung Cancer [NA]
The eRAPID online symptom reporting study in thoracic cancers has completed, including non-small cell lung cancer, small-cell lung cancer, a…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Breathe Easier II: A Dyad-based Multiple Behavior Intervention [NA]
A completed clinical trial evaluating a dyad-based multiple behavior intervention aimed at improving self-management, physical activity, str…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 [Phase 1]
A first-in-human Phase 1 trial of BMC128 in combination therapy evaluating a single dose level, across multiple cancers; status is active bu…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating ACY-241 in combination with nivolumab for unresectable non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer [Phase 2]
This ClinicalTrials.gov record reports a Phase 2 trial of first-line osimertinib for patients with EGFR-mutated non-small cell lung cancer; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors
A completed clinical trial evaluates quality of life and physical fitness in patients treated with immune checkpoint inhibitors for melanoma…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC [Phase 2]
Phase 2 study assessing pembrolizumab alone or after targeted radiation to a lesion in previously treated patients with stage IV non-small c…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC. [Phase 2]
Phase II trial investigating an anti-PD1 epigenetic therapy in non-small cell lung cancer has completed. Results were posted in May 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Pembrolizumab-PET Imaging [NA]
This clinical trial update notes the completion of a pembrolizumab-PET imaging study involving melanoma and non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer [Phase 3]
A phase 3 trial evaluating Aumolertinib with chemotherapy or as monotherapy compared to Osimertinib in EGFR-mutant non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations [Phase 2]
Phase 2 study evaluating JMT101 in combination with osimertinib for locally advanced or metastatic non-small cell lung cancer with EGFR comm…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib [Phase 2]
A Phase 2 trial of Alkotinib capsules in ALK-positive non-small cell lung cancer patients previously treated with Crizotinib has been termin…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer [NA]
Clinical trial update reporting pathologic and immunologic responses after ablative radiation in non-small cell lung cancer; results were po…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy [Phase 3]
A Phase 3 trial of denosumab in advanced non-small cell lung cancer showed survival improvement; the study was terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Study of AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports on the completed Phase 1 and Phase 2 study of AK104 in patients with locally advanced or metastatic non-s…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer [Phase 1, Phase 2]
A two-part Phase 1/2 trial of BIW-8962 as monotherapy in lung cancer has been terminated; the study evaluated Non-Small Cell Lung Cancer, Sm…
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations [Phase 3]
Phase 3 trial evaluating JMT101 with osimertinib versus cisplatin-pemetrexed in locally advanced or metastatic NSCLC with EGFR exon 20ins mu…
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy [Phase 2]
Phase 2 clinical trial evaluating nivolumab after neoadjuvant therapy and concurrent chemoradiation for stage III non-small-cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy [Phase 2]
Phase 2 trial evaluating neoadjuvant/adjuvant pembrolizumab combined with chemotherapy for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases [Phase 2]
Phase 2 trial investigating Almonertinib as first-line treatment for EGFR-mutant advanced non-small cell lung cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial investigating Glesatinib, Sitravatinib, or Mocetinostat in combination with Nivolumab for non-small cell lung cancer was termi…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Molecular Disease Characterization Initiative (MDCI) [Phase 2]
Phase 2 trial update for the Molecular Disease Characterization Initiative (MDCI) in non-small cell lung cancer; the study is terminated wit…
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Pharmacological Ascorbate for Lung Cancer [Phase 2]
This report indicates the completion of a Phase 2 trial evaluating pharmacological ascorbate for non-small cell lung cancer, with results po…
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT) [Phase 2]
Phase 2 clinical trial evaluating targeted natural killer (NK) cell adoptive immunotherapy after radiochemotherapy in patients with non-smal…
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 study evaluating the potential drug-drug interaction between TAK-788 and midazolam in participants with advanced non-small cell lung…